Syllabus Drug Chemistry
Syllabus Drug Chemistry
BABASAHEB AMBEDKAR
MARATHWADA UNIVERSITY,
AURANGABAD
Drug Chemistry
Reference Books:
1. Bioorganic chemistry By Hermann Dugas.
2. Biotransformation in organic chemistry By K. Faber.
3. Enzyme structure and Mecahanism By Alan Faber
4. Enzyme Catalysis in organic synthesis Vol. 1 By Karlheinz Drauz and Herbert Waldmann.
5. Bioorganic, Bioinorganic and Supramolecular chemistry By P. S. Kalsi and J. P. Kalsi.
6. Organic Chemistry IV Edn G.Marc Loudon.
7. Green Chemistry By Paul T. Anastas and John C. Warner
8. Green Chemistry By Rashmi Sanghi and M. M. Srivastav
CHECD 315: ORGANIC REACTIONS & REARRANGEMENTS
Teaching Hours: 60 Credit: 04
Reference Books:
1. Designing Organic Synthesis: S. Warren, Wiley.
2. Organic Chemistry: J. Clayden, N. Greeves, S. Warren and P. Wothers
3. Protective Groups in Organic Synthesis: T. W. Greene, G. M. Wuts.
4. Organic Syntheis: Jagdama Singh and L. D. S. Yadav
5. Advanced organic Chemistry: Part A & B, Reactions and Synthesis, F. A. Carey and R. J. Sundberg.
6. Organic Synthesis: M. B. Smith.
7. Principle of organic synthesis: Norman and Coxon
8. Advanced organic chemistry: Jerry March
9. Organic Photochemistry: Robert Kan
CHED 316: HETEROCYCLIC CHEMISTRY
Unit II 15 Hrs
Condensed five and six membered heterocycles: Benzofuran, Indole, Quinoline
Unit IV 15 Hrs
Five and six membered heterocycles with more than two hetero atoms: Synthesis, reactivity, aromatic
character and importance of following heterocycles: 1,2,3-triazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole,
tetrazole
Reference Books:
1. Heterocyclic Chemistry: vol. I, II, III: R. R. Gupta, M. Kumar and M. Gupta
2. Heterocyclic Chemistry: Joules and Mills
3. Modern heterocyclic Chemistry: L. A. Paquette (Benjamin)
4. Organic Chemistry: Jonathan Clayden
M. Sc. Second Year (Fourth Semester) Drug Chemistry
Unit III: Drug acting on Gastrointestinal tract (Drug acting on GIT) 15 Hrs
Introduction a) Gastric antacid: i) Treatment of gastric hyperacidity, ii) H2-receptor antagonists-Synthesis
of Ranitidine (Zantac) and Famotidine. b) Ulcerative colitis. c) Antispansmodics agents (Spasmolytic
agents), d) Anthelmintic agents: Introduction, anthelmintic agents, synthesis of mebendazole.
Reference books
1. Medicinal chemistry (Vol. I and II)-Burger.
2. The organic chemistry of drug design and drug action-R. B. Silverman (Academic Press)
3. Strategies for organic drug synthesis and designing - D. Lednicer Wiley.
4. Medicinal chemistry-William O. Foye
5. T. B. of Organic medicinal and pharmaceutical chemistry-Wilson and Gisvold’s (Ed. Robert F.
Dorge)
6. An introduction to medicinal chemistry-Graham L. Patrick.
7. An introduction to drug design-S. S. Pandeya and J. R. Dimmock (New age international)
8. Pharmacological basis of therapeutics-Goodman and Gilman’s (McGraw Hill)
9. Manual of patent practice and procedure-Patent office, India (2005)
OR
CHED 420: DRUG REGULATORY AFFAIRS
UNIT I 12 Hrs
1.1 Drug Regulatory Aspects (India) -
Indian drug regulatory authorities, Central and State regulatory bodies (State FDA, DCGI, CDSO); Drugs
and Cosmetics Act and Rules with latest Amendments (Special emphasis - Schedule M and Y); New
Drugs - (Importation, Registration, Development, Clinical Trials, B.E. studies);Various licenses - (Test
license, Import license for testing of drugs and API’s, Mfg., Contract and Loan license manufacturing.)
1.2 Good Manufacturing Practices (GMP) -Indian GMP certification, WHO GMP certification; ICH
guidelines for stability testing and other relevant ones (Q1 - Q10); Export permissions and manufacturing
for semi-regulated countries; Understanding of the plant lay-outs with special emphasis on the
environment & safety (HVAC, Water systems, Stores management, Effluent etc.); Quality Assurance and
Quality Control - Basic understanding for in-built quality.
UNIT II 12 Hrs
1.3 D rug Regulatory Aspects (International & highly regulated markets) - US Requirements - (for
Generic Drugs especially formulations); CDER, INDA, NDA, ANDA’s (types), CTD Formats of dossiers,
E-submission, US DMF (various types), IIG Limits, Orphan Drugs, Exhibit/Pivotal batches, Validation
batches, Various Guidance issued by CDER, OGD, Orange Book (and patents), RLD (Reference listed
drug) for BE studies and the norms for US
submission, Bioequivalence and dissolution recommendations, Packaging, Stability studies and the
Product Information Leaflet, US FDA Inspection (audits), Pre-approval Inspections and approvals; A brief
introduction to the guidelines for Europe, Japan, Australia, South Africa, Rest of the World (ROW) and
South & Latin American countries; GMP audits, role of Quality Assurance, product approvals and
supplies.
1.4 Introduction to IPR & Patents - Development of IP law in India, IPR regime, Introduction to IP laws in
India, Role of IP in Pharma industry growth.
UNIT III 12 Hrs
1.5 Patenting in India - Introduction, Patent legislation, Indian Patents Act 1970 and amendments,
Procedure for patent application, Grant and opposition proceedings, Patent licensing, Patent infringement
proceedings, IPAB - Role and functions (IP Appellate Board).
1.6 Patent search, Patent analysis & Patent drafting.
1.7 Allied Patents Related Issues:
1.8 Indian IP case studies- The Novartis case, Lipitor case, Natco versus Bayer case of compulsory
license, Patenting and traditional knowledge [Neem, Basmati, Haldi patent], Patenting of life forms
[Diamond versus Chakravarty case].
UNIT IV 12 Hrs
1.9 American & European patent system - Requirements for patenting: utility, novelty, non-obviousness.
Patent specification & claims, Patent infringement and Doctrine of Equivalents, Federal circuit and Patent
system in Europe 2.0 International treaties and conventions on IPR - Paris convention, PCT - an
introduction, PCT application & general rules, WTO / GATT system & Uruguay TRIPS, WIPO, Doha
declaration.
UNIT V 12 Hrs
2.1 Hatch Waxman Act and amendments, FDA Medicare Modernization Act,2003
2.2 Introduction to Geographical indication / Trademark/ copyright: Filing Procedures
Exploitation of patent, Abuse of patents, Compulsory licensing, Infringement analysis, Drug-
Patent Linkage
Reference books:
1. CDSO publications and updates of drug and Cosmetics act and rules (Govt. of India).
2. CDER Publications and Guidance
3. EMEA Publications and Guidance
4. Orange Book, ICH guidelines, Indian Patents Act
5. Country specific Regulatory Guidelines (available from internet)
6. Govt. Publications on issues affecting sales, distribution, manufacturing, excise, etc.
7. J. D. Nally, “Good manufacturing Practice for Pharmaceuticals” Informa Healthcare.
8. I. Kanfer & L. Shargel, “Generic Product Development BE issued” Informa Healthcare.
9. R. A. Guarino, “New Drug Approval Process. The Global challenges”. Informa Healthcare.
10. Watcher and Nash, “Pharmaceutical Process Validation”. Marcel Dekker.
11. Pharmaceutical Product Dev. IVIVC by Murthy, Sunkara and David
12. USPTO and WIPO Guidelines.
13. S. W. Deshpande, Drugs and Cosmetics Act, 1940 and Rules, 1945 and Drugs [Price
Control] Order, 1995.
CHED 421: LABORATORY COURSE V
(PART A: DRUG SYNTHESIS & PART B: DRUG ASSAY)
Laboratory Work Hours: 135 Credit: 4.5
=========================================================================
PART A: DRUG SYNTHESIS (25 Marks)
=========================================================================
=========================================================================